Floatz logo

DACARBAZINE

Non-hodgkin Lymphoma

New York Medical CollegeSmall moleculePhase 2Active
CCC
51/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
73/ 100

Competitive context

15 Active assets in the Non-hodgkin Lymphoma cohort.

Asset / SponsorPhaseRating
Cladribine
Sichuan University
Phase 2CCC
Romidepsin
Mayo Clinic
Phase 1/2CCC
Mad Cpr 1 And 2
New York Medical College
Phase 2CCC
RETINOL
St. Petersburg State Pavlov Medical University
Phase 2CCC
Cytosin-Arabinosid
New York Medical College
Phase 2CCC

View all 29 →

Same molecule, other indications

DACARBAZINE is also rated in:

metastatic melanomaDormant
BBB
Indicative ·
72 / 100
View asset →
cutaneous melanomaDormant
BBB
Indicative ·
72 / 100
View asset →
Hodgkins lymphomaDormant
BB
Indicative ·
71 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →